Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Ok are we still halted.... WTF?

<< Previous

Bullboard Posts

Next >>

Comment by polygraph46on Feb 16, 2021 5:19pm

222 Views

Post# 32579959

RE:RE:RE:RE:RE:RE:RE:Ok are we still halted.... WTF?

Biggi...........in regards to no answer, the Robster is putting in his hours working a busy intersection

with cap in hand. He has to as there is no cashola in the piggy. With your 100,000 shares, you are

one of many suffering longs on here hoping for a miracle rescue. As this point, we are lead to

believe from those on the leading edge ( over at the Conclave) that a new name is in the works for

nag, along with a sizzling press release about how they plan to take a new money eating entity

forward. The new name might be........claritasneedsyourdough......not totally unlike the old...Kalyhas

takenyourdough. ......pg46

<< Previous

Bullboard Posts

Next >>

Canadian oil company taps unconventional oil and gas asset in Egypt